Victory Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $151M | Sell |
664,768
-78,578
| -11% | -$14M | 0.08% | 242 |
|
|
2026
Q1 | $128M | Buy |
743,346
+51,872
| +8% | +$9.62M | 0.08% | 256 |
|
|
2025
Q4 | $138M | Buy |
691,474
+684,586
| +9,939% | +$124M | 0.08% | 240 |
|
|
2025
Q3 | $1.08M | Sell |
6,888
-356
| -5% | -$56.5K | ﹤0.01% | 1806 |
|
|
2025
Q2 | $1.1M | Sell |
7,244
-170,261
| -96% | -$22.7M | ﹤0.01% | 1812 |
|
|
2025
Q1 | $26.7M | Sell |
177,505
-148,442
| -46% | -$24.9M | 0.03% | 703 |
|
|
2024
Q4 | $60.2M | Sell |
325,947
-22,329
| -6% | -$4.3M | 0.06% | 392 |
|
|
2024
Q3 | $68.6M | Sell |
348,276
-117,418
| -25% | -$24.4M | 0.07% | 362 |
|
|
2024
Q2 | $96.2M | Buy |
465,694
+5,876
| +1% | +$1.33M | 0.1% | 252 |
|
|
2024
Q1 | $125M | Sell |
459,818
-7,759
| -2% | -$1.85M | 0.12% | 191 |
|
|
2023
Q4 | $111M | Buy |
467,577
+93,849
| +25% | +$18.5M | 0.12% | 209 |
|
|
2023
Q3 | $73.2M | Buy |
373,728
+4,826
| +1% | +$991K | 0.08% | 300 |
|
|
2023
Q2 | $77.6M | Sell |
368,902
-4,021
| -1% | -$800K | 0.09% | 295 |
|
|
2023
Q1 | $75.3M | Buy |
372,923
+32,142
| +9% | +$7.28M | 0.08% | 306 |
|
|
2022
Q4 | $74.3M | Buy |
340,781
+125,987
| +59% | +$27.5M | 0.09% | 307 |
|
|
2022
Q3 | $42.3M | Buy |
214,794
+126,149
| +142% | +$27.2M | 0.05% | 523 |
|
|
2022
Q2 | $19M | Sell |
88,645
-102,554
| -54% | -$25.1M | 0.02% | 850 |
|
|
2022
Q1 | $53M | Sell |
191,199
-41,113
| -18% | -$12.7M | 0.05% | 498 |
|
|
2021
Q4 | $87.5M | Sell |
232,312
-185,621
| -44% | -$72.1M | 0.08% | 334 |
|
|
2021
Q3 | $172M | Sell |
417,933
-54,826
| -12% | -$22.8M | 0.17% | 143 |
|
|
2021
Q2 | $175M | Sell |
472,759
-45,830
| -9% | -$15.3M | 0.17% | 145 |
|
|
2021
Q1 | $150M | Sell |
518,589
-39,527
| -7% | -$11M | 0.15% | 155 |
|
|
2020
Q4 | $139M | Sell |
558,116
-84,689
| -13% | -$20.2M | 0.16% | 167 |
|
|
2020
Q3 | $146M | Buy |
642,805
+499,581
| +349% | +$104M | 0.19% | 130 |
|
|
2020
Q2 | $25M | Buy |
143,224
+49,046
| +52% | +$7.83M | 0.03% | 691 |
|
|
2020
Q1 | $11.9M | Buy |
94,178
+58,577
| +165% | +$8.79M | 0.02% | 838 |
|
|
2019
Q4 | $5.44M | Buy |
35,601
+3,714
| +12% | +$514K | 0.01% | 1163 |
|
|
2019
Q3 | $4.22M | Buy |
31,887
+13,008
| +69% | +$1.74M | 0.01% | 1214 |
|
|
2019
Q2 | $2.68M | Buy |
18,879
+131
| +0.7% | +$17.8K | 0.01% | 1065 |
|
|
2019
Q1 | $2.72M | Sell |
18,748
-271,650
| -94% | -$35.7M | 0.01% | 1018 |
|
|
2018
Q4 | $32.9M | Sell |
290,398
-123,938
| -30% | -$15.5M | 0.08% | 395 |
|
|
2018
Q3 | $55.7M | Sell |
414,336
-9,501
| -2% | -$1.17M | 0.12% | 275 |
|
|
2018
Q2 | $47.6M | Buy |
423,837
+14,296
| +3% | +$1.55M | 0.1% | 323 |
|
|
2018
Q1 | $43.7M | Sell |
409,541
-25,165
| -6% | -$2.71M | 0.1% | 344 |
|
|
2017
Q4 | $47.6M | Buy |
434,706
+6,153
| +1% | +$670K | 0.1% | 319 |
|
|
2017
Q3 | $46.3M | Buy |
428,553
+14,264
| +3% | +$1.47M | 0.1% | 321 |
|
|
2017
Q2 | $41.9M | Sell |
414,289
-8,553
| -2% | -$787K | 0.1% | 345 |
|
|
2017
Q1 | $38M | Buy |
422,842
+8,049
| +2% | +$684K | 0.09% | 373 |
|
|
2016
Q4 | $31.6M | Buy |
414,793
+2,601
| +0.6% | +$198K | 0.08% | 441 |
|
|
2016
Q3 | $34.4M | Sell |
412,192
-20,971
| -5% | -$1.76M | 0.1% | 356 |
|
|
2016
Q2 | $35.7M | Buy |
433,163
+19,360
| +5% | +$1.59M | 0.14% | 254 |
|
|
2016
Q1 | $31.4M | Sell |
413,803
-77,031
| -16% | -$5.7M | 0.13% | 273 |
|
|
2015
Q4 | $39.5M | Buy |
490,834
+32,031
| +7% | +$2.31M | 0.16% | 220 |
|
|
2015
Q3 | $29.1M | Buy |
458,803
+23,651
| +5% | +$1.7M | 0.12% | 300 |
|
|
2015
Q2 | $30.6M | Buy |
435,152
+3,126
| +0.7% | +$231K | 0.11% | 305 |
|
|
2015
Q1 | $34.3M | Sell |
432,026
-187,523
| -30% | -$13.8M | 0.12% | 288 |
|
|
2014
Q4 | $39.4M | Buy |
619,549
+296,251
| +92% | +$18.6M | 0.15% | 239 |
|
|
2014
Q3 | $19.3M | Sell |
323,298
-91,484
| -22% | -$5.23M | 0.15% | 232 |
|
|
2014
Q2 | $22.2M | Sell |
414,782
-63,530
| -13% | -$3.49M | 0.15% | 231 |
|
|
2014
Q1 | $28.9M | Sell |
478,312
-175,688
| -27% | -$10.2M | 0.2% | 187 |
|
|
2013
Q4 | $34.7M | Buy |
654,000
+94,475
| +17% | +$4.74M | 0.24% | 144 |
|
|
2013
Q3 | $25.9M | Buy |
+559,525
| New | +$25.7M | 0.19% | 179 |
|
Other funds holding CRL
AI
Victory Capital Management's CRL Position: Q2 2026 in Review
Victory Capital Management reduced its Charles River Laboratories (CRL) stake by 11% in Q2 2026, selling an estimated $14M and leaving 664,768 shares worth $151M. The position accounts for 0.08% of the portfolio, ranked #242.
Victory Capital Management first reported a position in CRL in Q3 2013 and has held it in 52 quarters since. The position peaked at $175M in Q2 2021. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Victory Capital Management held 664,768 shares of Charles River Laboratories worth $151M as of Q2 2026.
- Victory Capital Management sold 78,578 Charles River Laboratories shares in Q2 2026, an estimated $14M.
- Charles River Laboratories made up 0.08% of Victory Capital Management's portfolio in Q2 2026, its #242 holding.
- Victory Capital Management first reported a position in Charles River Laboratories in Q3 2013 and has held it in 52 quarters since.
- Victory Capital Management's Charles River Laboratories position peaked at $175M in Q2 2021.
- 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.